Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
Authors:
- Carmen ManolioCMCarmen Manolio
- Concetta RagoneCRConcetta Ragone
- Beatrice CavalluzzoBCBeatrice Cavalluzzo
- Angela MaurielloAMAngela Mauriello
- Maria Lina TorneselloMaria Lina Tornesello
- Franco M. BuonaguroFranco M. Buonaguro
- Angelo Salomone MegnaAMAngelo Salomone Megna
- Giovanna D’aLessioGDGiovanna D’aLessio
- Roberta PentaRPRoberta Penta
- Maria TagliamonteMTMaria Tagliamonte
- Luigi BuonaguroLuigi Buonaguro
Open Access
- 15 October 2022
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 20 (1) , 1-20
Abstract
Background: People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry between HIV epitopes and tumor associated antigens and, consequently, a T cell cross-reactivity could provide an explanation for such an epidemiological evidence. Methods: Homology between published TAAs and non-self HIV-derived epitopes have been assessed by BLAST homology. Structural analyses have been performed by bioinformatics tools. Immunological validation of CD8+ T cell cross-reactivity has been evaluated ex vivo by tetramer staining. Findings: Sequence homologies between multiple TAAs and HIV epitopes have been found. High structural similarities between the paired TAAs and HIV epitopes as well as comparable patterns of contact with HLA and TCR α and β chains have been observed. Furthermore, cross-reacting CD8+ T cells have been identified. Interpretation: This is the first study showing a molecular mimicry between HIV antigens an TAAs identified in breast, prostate and colon cancers. Therefore, it is highly reasonable that memory CD8+ T cells elicited during the HIV infection may play a key role in controlling development and progression of such cancers in the PLWHA lifetime. This represents the first demonstration ever that a viral infection may induce a natural “preventive” anti-cancer memory T cells, with highly relevant implications beyond the HIV infection.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine, 2014
- Why must T cells be cross-reactive?Nature Reviews Immunology, 2012
- A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different PeptidesJournal of Biological Chemistry, 2012
- Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 ConferenceThe Lancet Infectious Diseases, 2010
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cellsBlood, 2009
- Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysisThe Lancet, 2007
- AIDS-Related Cancer and Severity of Immunosuppression in Persons With AIDSJNCI: Journal of the National Cancer Institute, 2007
- Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA PeptidesClinical Cancer Research, 2004
- Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopesJournal of General Virology, 2003